Alterity Therapeutics Limited
ATHE
$4.60
-$0.10-2.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.59M | -1.56M | -2.34M | -2.40M | -4.16M |
| Total Depreciation and Amortization | 21.50K | 21.10K | 23.70K | 24.30K | 24.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 134.50K | 131.70K | 244.60K | 251.50K | 100.30K |
| Change in Net Operating Assets | 447.10K | 437.80K | -654.70K | -673.20K | 1.36M |
| Cash from Operations | -990.20K | -969.70K | -2.72M | -2.80M | -2.67M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.40M | -2.35M | -- | -- | -- |
| Cash from Investing | -2.40M | -2.35M | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -29.40K | -29.40K | -34.10K | -34.10K | 22.20K |
| Issuance of Common Stock | 21.09M | 21.09M | 199.30K | 199.30K | 4.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.37M | -1.37M | -16.00K | -16.00K | -327.30K |
| Cash from Financing | 12.61M | 12.35M | 97.20K | 99.90K | 2.69M |
| Foreign Exchange rate Adjustments | -50.40K | -49.40K | -13.40K | -13.70K | 86.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.17M | 8.98M | -2.64M | -2.71M | 104.90K |